4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine

C165H252N48O2 — CID 157378633

IUPAC4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine
SMILESCC(C)(C)N1CCOCC1.CC(C)c1cnc(-n2cccc2)cn1.CC(C)c1cnc(-n2ccnc2)cn1.CC(C)c1cnc(N(C)C)cn1.CC(C)c1cnc(N)cn1.CC(C)c1cnc(N2CCCC2)cn1.CC(C)c1cnc(N2CCCCC2)cn1.CC(C)c1cnc(N2CCCCC2C)cn1.CC(C)c1cnc(N2CCN(C)CC2)cn1.CC(C)c1cnc(N2CCOCC2)cn1.CC1CCN(c2cnc(C(C)C)cn2)CC1.CCN(C)c1cnc(C)cn1.CCN(CC)c1ccc(C)cn1.Cc1cn(-c2cnc(C(C)C)cn2)cn1.Cc1cnc(C(C)C)cn1.Cc1nccn1-c1cnc(C(C)C)cn1
InChIInChI=1S/2C13H21N3.C12H20N4.C12H19N3.2C11H14N4.C11H17N3O.C11H17N3.C11H13N3.C10H12N4.C10H16N2.C9H15N3.C8H13N3.C8H12N2.C8H17NO.C7H11N3/c1-10(2)12-8-15-13(9-14-12)16-6-4-11(3)5-7-16;1-10(2)12-8-15-13(9-14-12)16-7-5-4-6-11(16)3;1-10(2)11-8-14-12(9-13-11)16-6-4-15(3)5-7-16;1-10(2)11-8-14-12(9-13-11)15-6-4-3-5-7-15;1-8(2)10-4-13-11(5-12-10)15-6-9(3)14-7-15;1-8(2)10-6-14-11(7-13-10)15-5-4-12-9(15)3;1-9(2)10-7-13-11(8-12-10)14-3-5-15-6-4-14;2*1-9(2)10-7-13-11(8-12-10)14-5-3-4-6-14;1-8(2)9-5-13-10(6-12-9)14-4-3-11-7-14;1-4-12(5-2)10-7-6-9(3)8-11-10;1-7(2)8-5-11-9(6-10-8)12(3)4;1-4-11(3)8-6-9-7(2)5-10-8;1-6(2)8-5-9-7(3)4-10-8;1-8(2,3)9-4-6-10-7-5-9;1-5(2)6-3-10-7(8)4-9-6/h2*8-11H,4-7H2,1-3H3;8-10H,4-7H2,1-3H3;8-10H,3-7H2,1-2H3;2*4-8H,1-3H3;7-9H,3-6H2,1-2H3;7-9H,3-6H2,1-2H3;3-9H,1-2H3;3-8H,1-2H3;6-8H,4-5H2,1-3H3;5-7H,1-4H3;5-6H,4H2,1-3H3;4-6H,1-3H3;4-7H2,1-3H3;3-5H,1-2H3,(H2,8,10)
InChIKeyBKPNOEOEZOIIFF-UHFFFAOYSA-N
MW2940.16 g/mol
LogP31.11
Rot. Bonds29

About 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine

4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine (PubChem CID 157378633) has the molecular formula C165H252N48O2 and a molecular weight of 2940.16 g/mol. Its IUPAC name is 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine.

Molecular Properties

Compound Name4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine
PubChem CID157378633
Molecular FormulaC165H252N48O2
Molecular Weight2940.16 g/mol
Exact Mass2938.11
IUPAC Name4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine
SMILESCC(C)(C)N1CCOCC1.CC(C)c1cnc(-n2cccc2)cn1.CC(C)c1cnc(-n2ccnc2)cn1.CC(C)c1cnc(N(C)C)cn1.CC(C)c1cnc(N)cn1.CC(C)c1cnc(N2CCCC2)cn1.CC(C)c1cnc(N2CCCCC2)cn1.CC(C)c1cnc(N2CCCCC2C)cn1.CC(C)c1cnc(N2CCN(C)CC2)cn1.CC(C)c1cnc(N2CCOCC2)cn1.CC1CCN(c2cnc(C(C)C)cn2)CC1.CCN(C)c1cnc(C)cn1.CCN(CC)c1ccc(C)cn1.Cc1cn(-c2cnc(C(C)C)cn2)cn1.Cc1cnc(C(C)C)cn1.Cc1nccn1-c1cnc(C(C)C)cn1
InChIInChI=1S/2C13H21N3.C12H20N4.C12H19N3.2C11H14N4.C11H17N3O.C11H17N3.C11H13N3.C10H12N4.C10H16N2.C9H15N3.C8H13N3.C8H12N2.C8H17NO.C7H11N3/c1-10(2)12-8-15-13(9-14-12)16-6-4-11(3)5-7-16;1-10(2)12-8-15-13(9-14-12)16-7-5-4-6-11(16)3;1-10(2)11-8-14-12(9-13-11)16-6-4-15(3)5-7-16;1-10(2)11-8-14-12(9-13-11)15-6-4-3-5-7-15;1-8(2)10-4-13-11(5-12-10)15-6-9(3)14-7-15;1-8(2)10-6-14-11(7-13-10)15-5-4-12-9(15)3;1-9(2)10-7-13-11(8-12-10)14-3-5-15-6-4-14;2*1-9(2)10-7-13-11(8-12-10)14-5-3-4-6-14;1-8(2)9-5-13-10(6-12-9)14-4-3-11-7-14;1-4-12(5-2)10-7-6-9(3)8-11-10;1-7(2)8-5-11-9(6-10-8)12(3)4;1-4-11(3)8-6-9-7(2)5-10-8;1-6(2)8-5-9-7(3)4-10-8;1-8(2,3)9-4-6-10-7-5-9;1-5(2)6-3-10-7(8)4-9-6/h2*8-11H,4-7H2,1-3H3;8-10H,4-7H2,1-3H3;8-10H,3-7H2,1-2H3;2*4-8H,1-3H3;7-9H,3-6H2,1-2H3;7-9H,3-6H2,1-2H3;3-9H,1-2H3;3-8H,1-2H3;6-8H,4-5H2,1-3H3;5-7H,1-4H3;5-6H,4H2,1-3H3;4-6H,1-3H3;4-7H2,1-3H3;3-5H,1-2H3,(H2,8,10)
InChIKeyBKPNOEOEZOIIFF-UHFFFAOYSA-N
XLogP31.11
TPSA512.32 Ų
H-Bond Donors1
H-Bond Acceptors50
Rotatable Bonds29
Heavy Atoms215
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002940.16
LogP ≤ 531.11
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1050

Analyze 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine?
The IUPAC name of 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine (CID 157378633) is 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine.
What is the SMILES notation for 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine?
The canonical SMILES for 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine is CC(C)(C)N1CCOCC1.CC(C)c1cnc(-n2cccc2)cn1.CC(C)c1cnc(-n2ccnc2)cn1.CC(C)c1cnc(N(C)C)cn1.CC(C)c1cnc(N)cn1.CC(C)c1cnc(N2CCCC2)cn1.CC(C)c1cnc(N2CCCCC2)cn1.CC(C)c1cnc(N2CCCCC2C)cn1.CC(C)c1cnc(N2CCN(C)CC2)cn1.CC(C)c1cnc(N2CCOCC2)cn1.CC1CCN(c2cnc(C(C)C)cn2)CC1.CCN(C)c1cnc(C)cn1.CCN(CC)c1ccc(C)cn1.Cc1cn(-c2cnc(C(C)C)cn2)cn1.Cc1cnc(C(C)C)cn1.Cc1nccn1-c1cnc(C(C)C)cn1.
What is the InChIKey of 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine?
The InChIKey is BKPNOEOEZOIIFF-UHFFFAOYSA-N. The full InChI is InChI=1S/2C13H21N3.C12H20N4.C12H19N3.2C11H14N4.C11H17N3O.C11H17N3.C11H13N3.C10H12N4.C10H16N2.C9H15N3.C8H13N3.C8H12N2.C8H17NO.C7H11N3/c1-10(2)12-8-15-13(9-14-12)16-6-4-11(3)5-7-16;1-10(2)12-8-15-13(9-14-12)16-7-5-4-6-11(16)3;1-10(2)11-8-14-12(9-13-11)16-6-4-15(3)5-7-16;1-10(2)11-8-14-12(9-13-11)15-6-4-3-5-7-15;1-8(2)10-4-13-11(5-12-10)15-6-9(3)14-7-15;1-8(2)10-6-14-11(7-13-10)15-5-4-12-9(15)3;1-9(2)10-7-13-11(8-12-10)14-3-5-15-6-4-14;2*1-9(2)10-7-13-11(8-12-10)14-5-3-4-6-14;1-8(2)9-5-13-10(6-12-9)14-4-3-11-7-14;1-4-12(5-2)10-7-6-9(3)8-11-10;1-7(2)8-5-11-9(6-10-8)12(3)4;1-4-11(3)8-6-9-7(2)5-10-8;1-6(2)8-5-9-7(3)4-10-8;1-8(2,3)9-4-6-10-7-5-9;1-5(2)6-3-10-7(8)4-9-6/h2*8-11H,4-7H2,1-3H3;8-10H,4-7H2,1-3H3;8-10H,3-7H2,1-2H3;2*4-8H,1-3H3;7-9H,3-6H2,1-2H3;7-9H,3-6H2,1-2H3;3-9H,1-2H3;3-8H,1-2H3;6-8H,4-5H2,1-3H3;5-7H,1-4H3;5-6H,4H2,1-3H3;4-6H,1-3H3;4-7H2,1-3H3;3-5H,1-2H3,(H2,8,10).
What are the key properties of 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine?
4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine has a molecular weight of 2940.16 g/mol, XLogP of 31.11, 29 rotatable bonds, 1 hydrogen bond donors, and 50 hydrogen bond acceptors.
Where does this data come from?
All data for 4-tert-butylmorpholine;N,N-diethyl-5-methylpyridin-2-amine;N,N-dimethyl-5-propan-2-ylpyrazin-2-amine;N-ethyl-N,5-dimethylpyrazin-2-amine;2-imidazol-1-yl-5-propan-2-ylpyrazine;2-(2-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylimidazol-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperazin-1-yl)-5-propan-2-ylpyrazine;2-(2-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-(4-methylpiperidin-1-yl)-5-propan-2-ylpyrazine;2-methyl-5-propan-2-ylpyrazine;2-piperidin-1-yl-5-propan-2-ylpyrazine;5-propan-2-ylpyrazin-2-amine;4-(5-propan-2-ylpyrazin-2-yl)morpholine;2-propan-2-yl-5-pyrrolidin-1-ylpyrazine;2-propan-2-yl-5-pyrrol-1-ylpyrazine is sourced from PubChem (CID 157378633), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).